Warning Letter of the Week: short attention span edition Hello friend AMERICAN WORKERS LOOKING FOR JOBS, In the article you read this time with the title Warning Letter of the Week: short attention span edition, we have prepared this article well for you to read and take information in it. hopefully the contents of the post Article bank, Article contracting, Article health, Article lecturer, Article manufacturing, Article marketing, Article property, Article public, Article teachers, Article telecommunications,what we write can you understand. okay, happy reading.

Judul : Warning Letter of the Week: short attention span edition
link : Warning Letter of the Week: short attention span edition

Warning Letter of the Week: short attention span edition

In a note to the Managing Director of Aurobindo, this amusing comment from the Center for Drug Evaluation and Research (emphasis mine):

1.  Changes to methods or controls were not reported to FDA through a supplement to an approved [redacted]. (21 CFR 314.97(a) and 314.70(c)(6)(i)) 

...Investigators observed, in your [redacted] API, non-carcinogenic impurities of [redacted] and [redacted] at levels up to [redacted]% and [redacted]%, respectively, in residual solvent testing for [redacted] API batches. These impurities are present in drug substances at levels exceeding the [redacted] USP specification limit for Any other individual impurity (i.e. NMT [redacted]%). These impurity levels are also above the ICH Q3A(R2) reporting threshold for drug substance impurities. 

Your Quality Unit failed to report to FDA these impurities, which were also above your internal reporting threshold limit of no more than [redacted]%. You updated the information in your Drug Master File (DMF) only after FDA investigators communicated during the inspection that you should be reporting all observed impurities above the reporting threshold.  

In your response, you explained a “scheduled regulatory update skipped our attention.” In addition, you stated you would undertake an additional CAPA for controls of residual solvents. Your response is inadequate, as you did not commit to conduct a full review of all impurities observed in all your APIs above the reporting threshold and ensure that your DMFs and [redacted] are updated accordingly...

I hate it when things skip my attention. 

Such is the article Warning Letter of the Week: short attention span edition

That's an article Warning Letter of the Week: short attention span edition this time, hopefully it can benefit you all. well, see you in other article postings.

You are now reading the article Warning Letter of the Week: short attention span edition with the link address https://americanworkerslooking.blogspot.com/2019/07/warning-letter-of-week-short-attention.html

Tweet

Subscribe to receive free email updates: